NEWS - HAPA pharm

HAPA pharm receives GMP certification
HAPA pharm (“HAPA” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice)

COVID-19: A message to our customers, suppliers and partners
HAPA pharm is actively responding to the situation of coronavirus (COVID-19) by following the recommendations of local and international authorities. We have proactively implemented measures that give priority to the health and safety of our employees, customers and partners, including

HAPA Medical becomes HAPA pharm
HAPA pharm is an internationally active company focusing on the research, development and marketing of cannabinoid-containing products and drug formulations. The company, which previously operated under the name of HAPA Medical, has established itself as a pharmaceutical producer. With its

Website Relaunch
Open source information on cannabinoids in health and disease Heureka, our new website is online! Our team has been working hard to optimize user experience, design, internationality and content. Let us know what you think! And thank you for your

Pressrelease November 2018
Käfer Dachgarten-Restaurant im Deutschen Bundestag Demnächst steht in Deutschland mit dem HAPA medical Vollspektrum Cannabis Extrakt THC2.5 CBD2.5 (Lösung) ein neues Extrakt zur Herstellung eines Rezepturarzneimittels aus medizinischem Cannabis zur Verfügung. Daher laden wir Journalisten der medizinischen Fachpresse herzlich zur

We grow innovation
HAPA medical partners with Australian Zelda Therapeutics for the advancement of clinical cannabinoid research While experimental studies have already unveiled many mechanisms of action for a wide array of cannabinoids, there is still a lack of proper clinical trials which